Idéal Investisseur Connexion Connexion
Français English
CAC 40 : Market open
7 970,89 pts
-1.36%


Last updated : 20/11/2026 - 12h41
🏠 Home   ➤    Stock news

Nanobiotix shares fall 13% in one week and give back most of their rebound

The Parisian oncology nanomedicine biotech slips at midday, in a Paris market trending lower. This decline extends a difficult week and places the stock in the lower half of the broader index ranking.


Nanobiotix shares fall 13% in one week and give back most of their rebound

A weekly decline that brings the stock back below all its moving averages

The stock loses 2.7% to €25.24, after a 13.09% drop over seven days that erases much of the sharp recovery seen in November.

The session takes place as the SBF 120 falls 1.22% to 6,037.76 points and the CAC 40 drops 1.16%, in a context of strong pressure on global technology stocks. Nanobiotix ranks near the bottom of the index, without being among the largest decliners.

Sanofi (+1.66%) and Eurofins Scientific (-0.26%), which operate in healthcare, show more resilient performance.

The share price is now below its three moving averages: the MM20 at €27.46 is 8.08% above, the MM50 at €26.07 is 3.18% above, and the MM200 at €29.90 is 15.59% above. The RSI at 46 remains neutral: the weekly decline has not exhausted the stock.

Cash of €110.9 million announced in September, funding through 2029

When publishing its first-half 2026 results on September 24, the company indicated that its cash of €110.9 million would allow it to finance its operations until 2029, and that it did not see any substantial doubt about its ability to continue its activity over the next twelve months. This financing horizon fits within the model of a biotech developing NBTXR3 (JNJ-1900), a radioenhancer combined with radiotherapy, in partnership with Johnson & Johnson.

The stock is listed in Paris as an ordinary share eligible for the PEA, and on the Nasdaq as ADSs, at a ratio of one ADS per share: the two lines most often move on the same day.

After a one-month gain of 33.9%, the weekly decline brought the stock back toward its mid-month level, above the support at €18.85 and below the resistance at €30.36.

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning ✓ Euronext data ✓ AI-powered analysis


Sector Pharmacie et biotechnologies › Biotechnologies


Context

Period
  • Period: S1 2026
Key reported figures
  • Revenue: 3,6 millions d'euros
  • Quarterly revenue: 3,6 millions d'euros
  • Net income: -34,3 millions d'euros
Guidance from the release
  • « la Société estime qu'elle disposera des liquidités suffisantes pour faire face à ses obligations financières […] pendant au moins les 12 prochains mois […] pas de doute substantiel quant à la capacité de la Société à poursuivre son activité » ; CP du 24/09 : trésorerie de 110,9 M€ « permettront de financer ses opérations jusqu'en 2029 »

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
✓ Avant 9h00 ✓ 1000+ inscrits ✓ 100% gratuit
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours sur les valeurs Euronext, chaque matin avant 9h.
tendance · 6 séances
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours